TRGel develops glucose-based biopolymers that can be used instead of calcium alginate for encapsulation.
TRGel has raised $256K in total funding. The most recent round was Grant. The last funding was announced in August 2021.
TRGel's investors include National Science Foundation.
TRGel is headquartered in Irvine, United States.
TRGel develops glucose-based biopolymers that can be used instead of calcium alginate for encapsulation.
TRGel is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TRGel — Funding & Investors." VCBacked, August 15, 2021, https://www.vcbacked.co/company/trgel. Accessed August 13, 2026.
VCBacked. (2021). TRGel — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/trgel
{{cite web |title=TRGel — Funding & Investors |url=https://www.vcbacked.co/company/trgel |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated